Ethicon, part of J&J, won FDA clearance for its ENSEAL X1 Large Jaw Tissue Sealer, a bipolar device used in open surgeries such as colectomies and hysterectomies for sealing vessels and other tissues.
It relies on the Ethicon Endo-Surgery generator that can power any other ENSEAL bipolar devices, as well as the company’s HARMONIC Ultrasonic surgical tools.
From the announcement:
The ENSEAL X1 Large Jaw Tissue Sealer represents the first in a new generation of ENSEAL® technology designed to provide secure vessel sealing and precise heat management in one device with the comfort and ergonomics demanded by advanced bipolar surgeons in today’s marketplace.
“Ethicon remains committed to addressing the critical needs of patients, ensuring they have access to the most effective treatment through continued innovation and product enhancement,” says Grace Chung, Ethicon Vice President, Energy Global Strategic Marketing. “By providing access to leading-edge technology in advanced bipolar energy, we are giving hospitals the ability to work with a single advanced energy provider and surgeons increased choice and the flexibility to meet a diverse set of clinical needs for their patients and procedures.”